Goldman Sachs’s Vascular Solutions Inc VASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-64,638
Closed -$3.63M 7242
2016
Q4
$3.63M Sell
64,638
-15,782
-20% -$804K ﹤0.01% 3331
2016
Q3
$3.88M Buy
+80,420
New +$3.75M ﹤0.01% 3265
2015
Q1
Sell
-18,810
Closed -$511K 7450
2014
Q4
$511K Sell
18,810
-13,795
-42% -$375K ﹤0.01% 5260
2014
Q3
$806K Buy
32,605
+559
+2% +$13.3K ﹤0.01% 4818
2014
Q2
$711K Buy
32,046
+365
+1% +$7.99K ﹤0.01% 5024
2014
Q1
$830K Sell
31,681
-15,056
-32% -$375K ﹤0.01% 4861
2013
Q4
$1.08M Buy
46,737
+3,824
+9% +$74.9K ﹤0.01% 4675
2013
Q3
$721K Buy
42,913
+9,344
+28% +$151K ﹤0.01% 4855
2013
Q2
$494K Buy
+33,569
New +$528K ﹤0.01% 4944

Other funds holding VASC

Goldman Sachs's VASC Position: Q1 2017 in Review

Goldman Sachs sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 64,638 shares — an estimated $3.63M sold.

Goldman Sachs first reported a position in VASC in Q2 2013 and held it in 9 quarters. The position peaked at $3.88M in Q3 2016. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

  • Goldman Sachs reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
  • Goldman Sachs sold 64,638 Vascular Solutions Inc shares in Q1 2017, an estimated $3.63M.
  • Goldman Sachs first reported a position in Vascular Solutions Inc in Q2 2013 and held it in 9 quarters.
  • Goldman Sachs's Vascular Solutions Inc position peaked at $3.88M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.

Based on Goldman Sachs's 13F filing for Q1 2017, filed 15 May 2017.